Treatment Patterns and Healthcare Costs in Newly Diagnosed Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As First-Line Therapy in the United States: A Retrospective Claims Database Analysis

被引：0
|
作者：
Chen, Lei [1 ]
Latremouille-Viau, Dominick [2 ]
Guerin, Annie [2 ]
Nitulescu, Roy [2 ]
Gagnon-Sanschagrin, Patrick [2 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Anal Grp Inc, Montreal, PQ, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy
    Efficace, Fabio
    Stagno, Fabio
    Iurlo, Alessandra
    Breccia, Massimo
    Cottone, Francesco
    Bonifacio, Massimiliano
    Abruzzese, Elisabetta
    Castagnetti, Fausto
    Caocci, Giovanni
    Crugnola, Monica
    Capodanno, Isabella
    Martino, Bruno
    Tiribelli, Mario
    Patriarca, Andrea
    Gozzini, Antonella
    Pregno, Patrizia
    Saussele, Susanne
    Cascavilla, Nicola
    Fozza, Claudio
    Bergamaschi, Micaela
    Binotto, Gianni
    Vignetti, Marco
    Rosti, Gianantonio
    LEUKEMIA, 2020, 34 (02) : 488 - 498
  • [22] The Outcome of Treatment-Free Remission after First-Line Nilotinib or Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients Is Different
    E.Nicolini, Franck
    Alcazer, Vincent
    Dulucq, Stephanie
    Hayette, Sandrine
    Cayuela, Jean-Michel
    Morisset, Stephane
    Bouvier, Christophe
    Mahon, Francois-Xavier
    Etienne, Gabriel
    Rea, Delphine
    BLOOD, 2021, 138
  • [23] Cost-effectiveness of nilotinib, dasatinib and imatinib as first-line treatment for chronic myeloid leukemia in Colombia, 2012
    Romero, Martin
    Chavez, Diana
    De los Rios, Magali
    Alvis-Guzman, Nelson
    BIOMEDICA, 2014, 34 (01): : 48 - 59
  • [24] EFFICACY AND SAFETY OF FIRST-LINE TREATMENT WITH NILOTINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS
    Gugliotta, G.
    Castagnetti, F.
    Breccia, M.
    D'Adda, M.
    Stagno, F.
    Levato, L.
    Carella, A. M.
    Martino, B.
    Tiribelli, M.
    Rege-Cambrin, G.
    Gozzini, A.
    Salvucci, M.
    Cedrone, M.
    Trabacchi, E.
    Usala, E.
    Scortechini, A. R.
    Luciano, L.
    Soverini, S.
    Alimena, G.
    Cavo, M.
    Martinelli, G.
    Pane, F.
    Saglio, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2016, 101 : S102 - S102
  • [25] EFFICACY AND SAFETY OF FIRST-LINE TREATMENT WITH NILOTINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS
    Gugliotta, G.
    Castagnetti, F.
    Breccia, M.
    D'Adda, M.
    Stagno, F.
    Levato, L.
    Carella, A. M.
    Martino, B.
    Tiribelli, M.
    Rege-Cambrin, G.
    Gozzini, A.
    Salvucci, M.
    Cedrone, M.
    Trabacchi, E.
    Usala, E.
    Scortechini, A. R.
    Luciano, L.
    Soverini, S.
    Alimena, G.
    Cavo, M.
    Martinelli, G.
    Pane, F.
    Saglio, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2016, 101 : 62 - 62
  • [26] First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies
    Gabriele Gugliotta
    Fausto Castagnetti
    Michela Apolinari
    Sara Pirondi
    Michele Cavo
    Michele Baccarani
    Gianantonio Rosti
    Drugs, 2014, 74 : 627 - 643
  • [27] First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Apolinari, Michela
    Pirondi, Sara
    Cavo, Michele
    Baccarani, Michele
    Rosti, Gianantonio
    DRUGS, 2014, 74 (06) : 627 - 643
  • [28] First-line treatment strategies for newly diagnosed chronic myeloid leukemia: a network meta-analysis
    Chen, Kang-Kang
    Du, Tai-Feng
    Wu, Ku-Sheng
    Yang, Wei
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3891 - 3910
  • [29] Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib
    Quintas-Cardama, Alfonso
    Jabbour, Elias J.
    LEUKEMIA RESEARCH, 2013, 37 (05) : 487 - 495
  • [30] Nilotinib In the First-Line Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia in Chronic Phase
    Garnock-Jones, Karly P.
    DRUGS, 2011, 71 (12) : 1579 - 1590
12345